Video Transcription
Video Summary
Keywords
PARP inhibitors
ovarian cancer
PRIMA study
PAOLA study
efficacy
first-line setting
BRCA mutation
biomarker deficiencies
improved outcomes
chemotherapy
bevacizumab
progression-free survival
homologous recombination deficiency
platinum-sensitive disease
pathology
Contact education@igcs.org for assistance.
Powered By